Avidity Biosciences Cash Flow Statement (2019-2025) | RNA

Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -2.55M-6.67M-10.38M-6.08M-10.48M-11.44M-16.27M-23.84M-26.35M-29.26M-38.49M-34.21M-45.69M-43.59M-50.45M-52.08M-46.86M-52.34M-60.34M-68.75M-70.68M-80.17M-102.46M-115.34M-156.66M-174.06M
Depreciation and Depletion 0.08M0.08M0.10M0.10M0.10M0.10M0.11M0.10M0.20M0.21M0.31M0.30M0.40M0.39M0.40M0.50M0.60M0.60M0.64M0.70M0.70M0.76M0.80M0.80M1.10M
Share-based Compensation 0.02M0.02M0.35M0.45M0.69M1.30M1.88M3.70M4.29M4.55M4.52M6.24M6.51M7.09M7.31M9.10M9.45M9.82M9.85M10.31M12.81M14.09M14.15M17.74M17.66M19.02M
Gains from Investment Securities 0.81M0.07M3.54M0.26M5.52M12.06M8.28M
Non-cash Items 65.08M1.89M
Cash from Operations -5.88M-5.02M-7.14M-7.79M-9.11M-13.07M-19.68M-28.14M-20.78M-26.21M-29.57M-35.55M-31.96M-39.19M-48.97M-49.81M-36.79M16.50M-70.38M-65.00M-65.61M-99.87M-124.83M-199.67M-156.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M-0.04M-0.03M-0.02M0.78M0.69M0.69M0.69M0.68M2.23M2.84M2.97M3.24M2.96M4.47M6.85M7.17M5.16M3.48M2.40M
Amortization of Deferred Charges 0.03M0.01M0.01M0.02M
Depreciation & Amortization (CF) 0.08M0.08M0.10M0.10M0.10M0.10M0.11M0.10M0.20M0.21M0.31M0.30M0.40M0.39M0.40M0.50M0.60M0.60M0.64M0.70M0.70M0.76M0.80M0.80M1.10M
Change in Working Capital
Change in Account Payables -1.23M5.78M
Change in Accured Expenses 0.29M0.92M-0.67M2.58M2.46M1.38M2.39M-1.81M3.29M2.17M4.96M1.62M5.45M6.29M-5.18M0.52M4.08M3.73M-6.54M12.51M13.81M15.41M-15.34M47.23M35.14M
Investing Activities
Capital Expenditures 0.01M0.09M0.01M0.28M0.57M0.24M0.53M0.71M0.80M1.71M0.76M1.32M-0.11M0.85M1.82M0.62M0.92M0.86M0.92M0.53M1.70M3.92M3.75M3.34M0.71M
Change in Acquisitions & Divestments 3.00M21.52M64.45M82.73M57.49M70.72M101.23M105.71M109.72M98.20M141.72M236.75M330.21M262.83M269.56M
Cash from Investing Activities -0.01M-0.09M-0.01M-0.84M-6.93M-0.53M2.87M-0.80M-84.06M-175.47M-17.64M10.93M-7.77M-195.68M46.05M-31.48M51.04M-32.75M-274.87M-482.41M-64.17M157.19M185.49M-587.93M
Financing Activities
Other financing activities 0.02M0.19M22.49M1.35M0.01M10.39M6.66M0.74M1.18M1.22M
Debt Issuance and Repayment
Long-Term Debt Issuances -0.01M
Long-Term Debt Repayments 0.70M0.70M0.70M3.98M
Change in Capital Stock
Shares Issued -0.01M0.01M0.02M274.04M0.02M0.30M174.36M24.10M38.28M39.32M243.08M22.44M38.11M238.65M200.25M323.76M-0.50M1.94M3.77M831.71M
Preferred Shares Issued 72.62M2.20M
Misc.
Cash from Financing Activities -0.71M71.82M1.32M271.61M-1.35M0.45M0.02M0.41M155.17M20.71M24.11M38.78M39.62M243.65M22.96M38.97M0.04M31.89M389.44M446.72M342.46M13.72M1.94M3.77M850.37M
Exchange Rate Effect 0.04M0.12M-0.02M
Change in Cash -6.61M66.71M-5.83M263.82M-11.30M-19.55M-20.19M-24.85M133.59M-89.56M-180.94M-14.41M18.59M196.70M-221.69M35.21M-68.23M99.43M286.32M106.85M-205.56M-150.32M34.34M-10.29M106.25M
Beginning Cash Balance 6.61M27.86M5.83M88.63M352.45M341.01M321.46M301.27M276.42M410.01M320.20M139.51M125.11M143.70M340.40M118.67M153.88M85.65M185.08M468.90M575.75M370.19M219.87M254.20M243.95M
Free Cash Flow -5.90M-5.11M-7.15M-8.07M-9.68M-13.31M-20.21M-28.84M-21.58M-27.92M-30.33M-36.87M-31.85M-40.04M-50.79M-50.43M-37.71M15.64M-71.30M-65.53M-67.32M-103.79M-128.58M-203.01M-156.88M
Net Cash Flow -6.61M66.71M-5.83M263.82M-11.30M-19.55M-20.19M-24.85M133.59M-89.56M-180.94M-14.41M18.59M196.70M-221.69M35.21M-68.23M99.43M286.32M106.85M-205.56M-150.32M34.30M-10.41M106.27M